Literature DB >> 7549307

Prevalence of and factors associated with childhood asthma in Hong Kong.

Y L Lau1, J Karlberg, C Y Yeung.   

Abstract

The prevalence of asthma and eczema in children between 3 and 10 years of age living in Hong Kong was determined by a questionnaire survey administered to the parents of 535 children in 1989. The prevalence of asthma was 6.0% (95% confidence limit (CI) 4.0-8.0%) and the prevalence of eczema 6.8% (95% CI 4.6-9.0%). Age, sex, parental smoking and breast feeding in early life did not show significant associations with asthma. However, four different measures were associated with the prevalence of asthma: the presence of eczema, high serum IgE level, high number of upper respiratory infections and a relatively high family income, with odds ratios of 7.6, 4.9, 4.5 and 2.7, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7549307     DOI: 10.1111/j.1651-2227.1995.tb13767.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

Review 1.  Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children.

Authors:  D G Cook; D P Strachan
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

2.  Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood.

Authors:  B F Habbick; M M Pizzichini; B Taylor; D Rennie; A Senthilselvan; M R Sears
Journal:  CMAJ       Date:  1999-06-29       Impact factor: 8.262

3.  Time-trends for eczema prevalences among children and adults from 1985 to 2015 in China: a systematic review.

Authors:  Wei Liu; Jiao Cai; Chanjuan Sun; Zhijun Zou; Jialing Zhang; Chen Huang
Journal:  BMC Public Health       Date:  2022-07-05       Impact factor: 4.135

Review 4.  Risk factors of asthma in the Asian population: a systematic review and meta-analysis.

Authors:  Yang Yie Sio; Fook Tim Chew
Journal:  J Physiol Anthropol       Date:  2021-12-09       Impact factor: 2.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.